Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans.
about
Targeting cellular energy production in neurological disorders.Statin-induced myopathy: the two faces of Janus.Treating statin-intolerant patientsPharmacogenomics and pharmacogenetics of cholesterol-lowering therapy.Evidence for metabolic aberrations in asymptomatic persons with type 2 diabetes after initiation of simvastatin therapyBenefits and risks assessment of simvastatin in familial hypercholesterolaemia.Effect of Coenzyme Q10 Supplementation in Statin-Treated Obese RatsProtection of rat skeletal muscle fibers by either L-carnitine or coenzyme Q10 against statins toxicity mediated by mitochondrial reactive oxygen generationCoenzyme Q10: is there a clinical role and a case for measurement?Molecular mechanisms of statin intolerancePlasma Coenzyme Q10 Predicts Lipid-lowering Response to High-Dose AtorvastatinClinical characterization and molecular mechanisms of statin myopathy.A current approach to statin intolerance.The effects of statin medications on aerobic exercise capacity and training adaptations.Statins and modulation of oxidative stress.No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy.Isoprostane 8-epi-PGF2alpha is frequently increased in patients with muscle pain and/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapy.The effects of 2 weeks of statin treatment on mitochondrial respiratory capacity in middle-aged males: the LIFESTAT study.Red yeast rice and coenzyme Q10 as safe alternatives to surmount atorvastatin-induced myopathy in hyperlipidemic rats.Statin-associated muscle symptoms: position paper from the Luso-Latin American Consortium.Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update.
P2860
Q34266266-2CD84329-12F8-4E1B-9836-4F1882503F3AQ34554637-89773F7A-622E-4C62-BBBF-CC5E8EAB5BF2Q35110510-0E2DE4EC-BFA7-4588-8705-D00E097B9042Q35127790-ABB89CFA-782D-43E5-B008-AFAB42F69E25Q35875974-A95D5521-C6F2-4E9F-AE4E-B5C83265AE9CQ36081978-71474102-0C32-4F34-B4EE-20F6656A45CDQ36640423-B33872E2-F308-4250-ACEC-7EF4DD46344FQ36844636-26F92C69-5718-497D-B72C-448DFF8B5FD4Q36869671-AC71C15C-BE4C-4FB7-AA33-7B425EE4C6B0Q36958324-4CB798C5-5CFD-4BA7-9ED5-F2954FE5CAF9Q37005510-61D6B7A4-3E99-47A2-97B8-DDF85430DB5BQ37230383-8F6E0C44-95BB-4FFD-89F0-8F683946A1C3Q38204184-D0FEE4C7-43A2-4BDF-AB88-5F9A75A90D25Q38228143-1ABF88EA-CA6D-4E01-B8F5-67555CECF3CFQ43215640-59D39588-AAF5-4442-AF2A-FFC744A64A49Q43661914-797107BC-743B-4BA5-909E-70974AB7CDB4Q43700112-F7578120-7982-4CA7-8CE3-71917292469DQ47962524-28640B5B-C365-4D1A-BE1D-81F492BA92E5Q50469720-E38A91E2-5938-4149-BB1F-A692338AF4E2Q51752364-86F1B295-B0E5-42A3-83DE-A75858A6273DQ51761248-7EE21173-B979-462C-BEE0-9E77A882D3DF
P2860
Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Decreases in serum ubiquinone ...... mvastatin treatment in humans.
@ast
Decreases in serum ubiquinone ...... mvastatin treatment in humans.
@en
Decreases in serum ubiquinone ...... mvastatin treatment in humans.
@nl
type
label
Decreases in serum ubiquinone ...... mvastatin treatment in humans.
@ast
Decreases in serum ubiquinone ...... mvastatin treatment in humans.
@en
Decreases in serum ubiquinone ...... mvastatin treatment in humans.
@nl
prefLabel
Decreases in serum ubiquinone ...... mvastatin treatment in humans.
@ast
Decreases in serum ubiquinone ...... mvastatin treatment in humans.
@en
Decreases in serum ubiquinone ...... mvastatin treatment in humans.
@nl
P2093
P1476
Decreases in serum ubiquinone ...... mvastatin treatment in humans.
@en
P2093
Himberg JJ
Jokelainen K
Laaksonen R
Tikkanen MJ
P356
10.1016/0009-9236(95)90266-X
P407
P577
1995-01-01T00:00:00Z